C-2PZ1Rejuvenation Technologies
telomere extension, modified mRNA, lipid nanoparticles
repairingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-2PZ1
C-2PZ1C-2PZ1telomere extension, modified mRNA, lipid nanoparticles
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Rejuvenation Technologies states that telomeres are a key mechanism of aging: they describe telomeres as protective DNA caps that shorten over time, and argue that when they become too short cells can no longer function, making this a major cause of aging. The company presents telomerase mRNA therapy as a way to reverse years of telomere shortening in days and frames its strategy as making safe, rapid telomere extension broadly and quickly available for aging and serious diseases in which short telomeres play a causal or strongly aggravating role.
SourceRejuvenation Technologies states that short telomeres are major drivers of disease and aging because telomeres, the protective caps of DNA, shorten over time and eventually become too short for cells to function properly. The company says its approach is to use TERT mRNA, a messenger RNA encoding telomerase, to extend telomeres, reverse years of telomere shortening in days, and treat fatal diseases of aging.
Source